A Phase IIb Randomized, Double-Blind, Placebo-Controlled Clinical Trial of Topical Bacteriophage T4 Endonuclease V in Renal Allograft Recipients With a History of Non-Melanoma Skin Cancer.
Phase of Trial: Phase II
Latest Information Update: 04 Jun 2013
At a glance
- Drugs T4N5-liposomes (Primary)
- Indications Skin cancer
- Focus Biomarker; Therapeutic Use
- 31 Aug 2018 Biomarkers information updated
- 11 Aug 2011 Actual end date (Nov 2010) added as reported by ClinicalTrials.gov.
- 11 Aug 2011 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.